[ST-elevation myocardial infarction (STEMI) in the elderly]

Ann Cardiol Angeiol (Paris). 2018 Dec;67(6):417-421. doi: 10.1016/j.ancard.2018.10.003. Epub 2018 Oct 28.
[Article in French]

Abstract

Admission in cardiology departments of patients over 80 years old, even nonagenarians, for ST-segment elevation myocardial infarction (STEMI) is not uncommon in 2018. The management of these high risk and polypathological patients, with atypical clinical presentation, is not based on international guidelines or randomized studies, but rather on retrospective studies, expert consensus, and common sense. Each decision has to be individualized to the patient's situation. This review, after a clinical case, aims to guide the clinician in the specific management of these patients, from the symptoms, to reperfusion strategy, and, as fast as possible, hospital discharge.

Keywords: Antithrombotic therapy; Antithrombotiques; Elderly; ST-elevation myocardial infarction; Sujet âgé; Syndrome coronaire aigu avec sus-décalage du segment ST.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Cardiac Rehabilitation
  • Drug Therapy, Combination
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Myocardial Revascularization
  • Platelet Aggregation Inhibitors / therapeutic use
  • ST Elevation Myocardial Infarction / diagnosis*
  • ST Elevation Myocardial Infarction / therapy*

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors